---
title: More Savings Are Possible for Oncology Care Model, ASCO Study Says
description: A real-world study helped show how pegfilgrastim biosimilar can improve savings in the Oncology Care Model and its successor, the Oncology Care First Model, according to findings presented at ASCO20 Virtual, the annual meeting of the American Society of Clinical Oncology.
---

# Newsroom

For Press Contact

[media@integraconnect.com](mailto:media@integraconnect.com)

Announcements

[In The News](https://insights.integraconnect.com/news?type=in-the-news) [Thought Leadership](https://insights.integraconnect.com/news?type=thought-leadership)

[

Back

](https://insights.integraconnect.com/news?type=in-the-news)

### More Savings Are Possible for Oncology Care Model, ASCO Study Says

Jun 2, 2020

Payers

Specialty Practices

Click here to [AJMC.](https://www.centerforbiosimilars.com/view/more-savings-are-possible-for-oncology-care-model-asco-study-says)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Integra Connect",
    "url" : "https://insights.integraconnect.com/news/author/integra-connect"
  },
  "dateModified" : "2023-05-23T18:49:56.973Z",
  "datePublished" : "2020-06-02T12:45:00.000Z",
  "headline" : "More Savings Are Possible for Oncology Care Model, ASCO Study Says",
  "mainEntityOfPage" : {
    "@id" : "https://insights.integraconnect.com/news/more-savings-are-possible-for-oncology-care-model-asco-study-says",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://insights.integraconnect.com/hubfs/IntegraConnect%20/ic-logo-text-dark-gray.png"
    },
    "name" : "Integra Connect"
  }
}
```